$3.53
-0.30-7.83%
Last update: Oct 23, 8:32 AM
Verrica Pharmaceuticals Inc (VRCA) Stock Price, Quote, News & History
VRCANASDAQ
Verrica Pharmaceuticals shares positive preliminary results from Part 2 of its Phase 2 trial for VP-315 in treating basal cell carcinoma, showing promising...
You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.
Other companies in Verrica Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Verrica Pharmaceuticals has a consensus price target of $54.83.
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $3.71 last updated October 23, 2026 at 8:32 AM EDT.
There are no upcoming dividends for Verrica Pharmaceuticals.
Verrica Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Verrica Pharmaceuticals.
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered...
